Introduction: A large number of congenital hypothyroidism (CH) cases in Iran are transient. This study was designed to investigate the aetiology of permanent CH (PCH) by thyroid scintigraphy (TS) and its relationship with the first diagnostic thyrotropin (TSH). Material and methods: During 12 years (2005)(2006)(2007)(2008)(2009)(2010)(2011)(2012)(2013)(2014)(2015)(2016)(2017) of CH screening in southwest Iran, all infants referred with the diagnosis of CH were followed until their third birthday, when they were re-evaluated for serum T4, TSH after discontinuing the treatment for 3-4 weeks. If the last test indicated a PCH state (TSH >10 mU/L with any levels of T4), TS was performed, and, based on the results, the patients were categorised as agenesis, dysgenesis (sublingual, thyroglossal cyst), and normal/diffuse goitre (indicating dyshormonogenesis). Results: After excluding all transient CH subjects, 224 permanent CH cases were enrolled (52.7% female). Seasonal distributions were as follows: spring: 25.7%, summer: 27.9%, autumn: 20.3%, and winter: 26.1%. No significant differences were found between females and males and the different modes of delivery (55.4% were delivered by caesarean section) regarding T4, TSH (p > 0.05). Of a total of 213 performed scans, 20.7% had agenesis, 36.2% had dysgenesis, and 43.2% were normal or goitrous. Those with agenesis/dysgenetic thyroid had a lower T4 and a higher TSH than those with normal scans. However, the differences were not significant. Compared to those who had TSH < 40 mU/L, patients with TSH ≥ 40mU/L had 46% (95% CI; 1.06-2.02) more risk of agenesis or dysgenesis in TS. Conclusions: More than 40% of PCH are caused by dyshormonogenesis in Iran. Having a TSH ≥ 40 mU/L after the first week of life significantly raises the probability of thyroid agenesis/dysgenesis as the cause. 
Introduction
Congenital hypothyroidism (CH) was reported to be more prevalent in the Asian population [1] . A large number of cases were reported as transient [2, 3] , possibly caused by maternal and/or environmental factors [4] [5] [6] . In these situations, the clinician must be careful to avoid unnecessary treatment while not losing any (AJUMS). There were no requirements for free and informed consent because there have been no changes in medical procedures such as additional blood sampling or imaging, and the participants were not identified. Moreover, no additional charges were imposed on the subjects. The author was the only focal point for the referral and follow-up of the screening program authorised by AJUMS. They were followed up until their third birthday, and then re-evaluation was performed for thyroid function tests (T4, TSH) following a 3-4-week treatment discontinuation. At this stage, those who had normal TSH were labelled as transient CH and were followed with scheduled rechecks for two more years to make sure that there was no recurrence. Those who had TSH rising (> 10 mU/L in the first or subsequent tests after levothyroxine discontinuation) were considered as permanent CH and were investigated by thyroid scintigraphy by technetium pertechnetate 99m ( Tc-99m TS). Based on the TS results, they were categorised as agenesis (absence of thyroid uptake), dysgenesis (hypoplastic, hemiagenesis, sublingual, submandibular, ectopic, or thyroglossal cyst), and dyshormonogenesis (normal location of thyroid with normal or increased size and technetium uptake) (Fig. 1) . In four of the subjects, thyroid ultrasonography was performed instead, due to concerns about radiation or poor cooperation. A normal size of thyroid categorised them as dyshormonogenesis.
Data regarding sex, month and season of birth, mode of delivery (caesarean section, or vaginal delivery), birth order, first diagnostic serum T4, TSH level, third year re-evaluation TSH values, and the TS results were collected and analysed to find their relationships with the outcome.
CH subjects secondary to hypophyseal disorder were excluded from the study.
Statistical analysis
Statistical analysis of the data was performed using Statistical Package for the Social Sciences 16.0 (SPSS, Inc., Chicago, IL, USA, Microsoft) software. Results were expressed as mean ± standard deviation. Student's t-test was used for the comparison of the means for numeric variables and the chi-square test for comparing the means for non-numeric variables. Relative risk index was used for risk assessment. P values < 0.05 were considered as significant.
Results
During the study, 224 [118 female (52.7%); female to male = 1.11) subjects with confirmed permanent primary CH were enrolled. Seasonal distributions were as permanent CH subject [7] . According to most CH screening plans [8] , a heal prick whole blood thyrotropin (TSH) measurement and, if needed, a confirmatory serum test for thyroxine (T4) and TSH are tests required for the diagnosis and the appropriate management of all neonates [1] . In screening programs for common congenital disorders, some additional investigations are included with different aims. Prevention of having another sick baby by genetic studies, similar to what is being performed for phenylketonuria, has no place in the CH program. However, determining the underlying aetiology and outcome by thyroid scintigraphy (TS) is of great importance [9, 10] . Some researchers have investigated the CH aetiology by TS at the time of diagnosis [11, 12] . However, performing TS does not change the treatment plan during the early years of management. Nevertheless, if it reveals a dysplastic thyroid gland (absence or ectopic, usually a small sublingual gland), parents can be told that the infant will need lifelong therapy.
It is commonly recommended that all patients be re-evaluated [13] after their third birthday [14] (when the critical period of brain development has passed), with a short period of treatment discontinuation to confirm if they are permanent or transient [5] . This is the best opportunity to exclude transient subjects and leave other investigations only for those with permanent CH.
Based on the high prevalence of CH in Iran where almost half of the cases have been transient [15, 16] and the popularity of consanguinity [17] is reported to have increased the CH prevalence mostly due to dyshormonogenesis rather than dysgenesis [18] , this study was designed to determine the different aetiologies of permanent CH in this country, using thyroid scintigraphy (TS), and to investigate the relationship between the first diagnostic serum TSH and TS results.
This study is the biggest study regarding the case number and the study course, which helped determine the aetiology of permanent CH after excluding all transient subjects in an Asian country with a high rate of consanguinity. It shows the role of genetics as the cause of dyshormonogenesis as well as more severe thyroid dysfunction in patients with agenesis/dysgenesis compared to dyshormonogenesis.
Material and methods
The screening program for CH started in Iran in 2005. During 12 years of study (until 2017) , all subjects with the diagnosis of CH (diagnosed by the author since early life or referred to the author at any age as a focal point and paediatric endocrine consultant) were studied.
The study was approved by the Ethics Committee of Ahvaz Jundishapur University of Medical Sciences PRACE ORYGINALNE follows: spring: 25.7%, summer: 27.9%, autumn: 20.3%, and winter: 26.1%.
With regard to the mode of delivery, 44.6% were born via normal delivery and 55.4% by caesarean section (C/S).
Regarding the birth order, 46.1% were the first, 32% the second, 11.7% the third, 5.8% the forth, 3.9% the fifth, and 0.5% the sixth child of their families. Of a total of 213 performed scans, 44 subjects (20.7%; F/M = 24/20 = 1.2/1) had agenesis, 77 (36.2%; F/M = 51/26 = 1.96/1) had dysgenesis, and 92 (43.2%; F/M = 38/54 = 0.7/1) were normal or goitrous (indicating dyshormonogenesis) (Tab. I).
There were no significant differences between females and males regarding T4 as well as TSH at the time of diagnosis (p > 0.05). Infants born via C/S had more serum values for both T4 and TSH (6.49 ± 10.7 vs. 4.99 ± 3.7 and 109.38 ± 165.7 vs. 85.30 ± 83.3, respectively) but these differences were not significant (p > 0.05).
Compared to those who had normal scans, patients with thyroid agenesis/dysgenesis had lower T4 (4.8 ± 3.5 vs. 7.65 ± 12.8 mg/dL) and higher TSH (125.8 ± 169.3 vs. 103.5 ± 118.5 mU/L) but none was significant (p > 0.05).
Compared to those who had TSH < 40 mU/L, patients with TSH ≥ 40 mU/L had a 46% (RR = 1.46; CI 95%: 1.06-2.02) higher risk of having abnormal TS results (Fig. 2) .
Discussion
As was expected, higher neonatal serum TSH values were found in those with athyreosis/dysgenesis com- pared to subjects with dyshormonogenesis, indicating greater severity of the disorder and requiring serious follow-up in these subjects.
Iranpour et al. [11] , in a study on 116 neonates with the diagnosis of CH requiring replacement levothyroxine treatment, performed early pre-treatment TS to classify them based on aetiology. They found that only 28.5% of them were athyreotic and 6% had dysgenesis; all the rest (65%) had a normal scan result. This study showed a significantly higher TSH value in those with agenesis. Similarly to Iranpour's study [11] , the author also found higher TSH levels in athyreotic subjects, but the distribution of our patients in the TS classification was different (Table II) . The smaller percentage of normal scans (≈ 40% dyshormonogenesis) in our study was due to the exclusion of transient cases before scanning.
El-desouki et al. [12] in Saudi Arabia designed a study similar to the previously-mentioned study and performed scanning for 147 CH patients . Their results were similar to our study (Tab. II).
Albert et al. reviewed the incidence of CH in New Zealand in a screening program covering 18 years [18] . Near two thirds of their cases were found to have dyshormonogenesis. An interesting point of their study was the increasing incidence of CH in New Zealand, mostly related to dyshormonogenesis. They explained this rise by the increase in Asian population immigration to New Zealand during that period. Another study performed by Eugene et al. [19] on 148 permanent CH subjects in Quebec, Canada reported only 15% of normal scan results, matching with a pattern of CH aetiology in a typical western country, which was mostly caused by sporadic dysgenesis rather than familial genetically-based dyshormonogenesis. Table 2 shows a brief comparison of the five mentioned studies and their findings conducted in different countries.
Regarding the mode of delivery, 44.6% were born via vaginal delivery (VD) and 55.4% by caesarean section (C/S). This finding is close to what we see in the general population in Iran. This high prevalence of C/S deliveries is related to women's preferences rather than obstetric issues.
Turan's study in Turkey [20] showed an insignificantly higher TSH value in neonates born via VD compared to those via C/S, but similar to the study of McElduff et al. [21] ; our subjects with a history of C/S had a slightly higher mean for T4 and TSH, although these differences were not significant. After excluding personal interests, those with caesarean deliveries are likely to have valuable differences in this regard.
Regarding the birth order, 90% of the cases were born as the first, the second, or the third child of their families. This only showed a higher attitude of parents to have only one or two children at most. However, some studies [22] have reported a change in CH prevalence in different birth orders. In concordance with the study of Rosenthal [23] , birth order in our CH subjects was not significantly different from that of the general population.
Seasonal distributions were found to be as follows: spring: 25.7%, summer: 27.9%, autumn: 20.3%, and winter: 26.1%. The author's previous study (6) in this region had disclosed a different pattern: spring: 19%, summer: 13.4%, autumn: 32.4%, and winter: 35.2%. In an opposite direction, Hashemipour et al. [24] reported a higher prevalence of CH in the warm season of the year. The two studies above had enrolled both transient and permanent CH patients, but the present research surveyed only permanent CH subjects. This may explain the aforementioned difference in seasonal patterns. Higher incidence of CH in cold or warm seasons of the year were related mostly to the aetiology of transient CH, and the regular incidence of CH over the year in this study matches with the aetiologies of permanent CH, not changing over the year.
Study limitations
In this study, all negative (no uptake) TS indexes were considered as agenesis, but there are some other possibilities. Absence of uptake can also be seen by TSHb gene mutations, TSH receptor inactivating mutations, iodide trapping defects, and maternal transfer of thyrotropin receptor blocking antibodies (TRB-Ab). Thyroid ultrasonography and other investigations such as the measurement of serum thyroglobulin or TRB-Ab will help differentiate these aetiologies from thyroid agenesis.
Actually, a combination of thyroid scan and ultrasonography provides maximal information to the clinician about thyroid function and its anatomic status. Then the real rate of dyshormonogenesis could be a little bit higher than what was reported in this study.
Conclusions
More than 43% of permanent CH subjects in Iran are caused by dyshormonogenesis. Compared to those with TSH < 40 mU/L, higher values have greater risk of having abnormal thyroid structure.
